🇺🇸 FDA
Company

ASSEMBLY

ASSEMBLY BIOSCIENCES, INC.

ASMB pharma USA

Quick answer

ASSEMBLY is a pharma company (ASMB) headquartered in SOUTH SAN FRANCISCO, CA, USA with 14 tracked pipeline programs.

Pipeline (14)

project

ABI-H0731

Chronic Hepatitis B

Phase 2 · small_molecule · terminated

6 trials project

ABI-H2158

Chronic Hepatitis B

Phase 2 · small_molecule · completed

3 trials project

VBR

Chronic Hepatitis B

Phase 2 · small_molecule · terminated

1 trials project

standard of care (SOC) Nucleoside reverse transcriptase inhibitor (NrtI)

Chronic Hepatitis B

Phase 2 · small_molecule · terminated

1 trials project

ABI-1179

Recurrent Genital Herpes Simplex Type 2

Phase 1 · small_molecule · completed

1 trials project

ABI-4334

Chronic Hepatitis B

Phase 1 · small_molecule · completed

1 trials project

ABI-4334 Tablet

Chronic Hepatitis B

Phase 1 · small_molecule · completed

1 trials project

ABI-5366

Recurrent Genital Herpes Simplex Type 2

Phase 1 · small_molecule · completed

1 trials project

ABI-6250

Hepatitis Delta Virus

Phase 1 · small_molecule · completed

1 trials project

ABI-H2158 Reference Formulation

Chronic Hepatitis B

Phase 1 · small_molecule · completed

1 trials project

ABI-H3733

Chronic Hepatitis B

Phase 1 · small_molecule · completed

1 trials project

ABI-H3733 Liquid Oral Dosage Form

Chronic Hepatitis B

Phase 1 · small_molecule · completed

1 trials project

ABI-M201

Ulcerative Colitis Chronic Mild

Phase 1 · small_molecule · terminated

1 trials project

Vebicorvir (VBR)

Chronic Hepatitis B

Phase 1 · small_molecule · completed

1 trials

Patents (8)

patent

US 12030869

5-membered heteroaryl carboxamide compounds for treatment of HBV

Expires Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11814376

Hepatitis b core protein modulators

Expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11560370

5-membered heteroaryl carboxamide compounds for treatment of HBV

Expires Mon Jan 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11331365

Multispecific protein drug and library thereof, preparing method therefor and ap

Expires Mon May 12 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11078170

Cyclic sulfamide compounds and methods of using same

Expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11040965

Process for making Hepatitis B core protein modulators

Expires Mon Jun 17 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10987360

Hepatitis B core protein modulators

Expires Mon Apr 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10968211

Hepatitis B core protein modulators

Expires Mon Apr 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)